Zymenex A/S
- Country
- 🇩🇰Denmark
- Ownership
- Subsidiary
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.zymenex.com
Clinical Trials
22
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Evaluation of Long-term Efficacy of Treatment With Lamazym
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- Zymenex A/S
- Target Recruit Count
- 18
- Registration Number
- NCT02478840
- Locations
- 🇩🇰
Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark
Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Zymenex A/S
- Target Recruit Count
- 10
- Registration Number
- NCT01681940
- Locations
- 🇧🇪
Kinderneurologie Metabole Ziekten, UZ Brussel, Laarbeeklaan 101, Brussel, Belgium
🇩🇰Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark
🇪🇸Servicio de Pediatría, Hospital Materno Infantil, Reina Sofía, Avda Menéndez Pidal sn, Córdoba, Spain
A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Zymenex A/S
- Target Recruit Count
- 25
- Registration Number
- NCT01681953
- Locations
- 🇩🇰
Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark
🇫🇷Hôpital Femme Mère Enfant, Lyon, 59 boulevard Pinel, Bron, France
🇫🇷Hôpital Trousseau, Service de neuropédiatrie, Centre Référence des Maladies Lysosomales, 26 avenue du Docteur Arnold Netter, PARIS Cedex 12, France
Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
- First Posted Date
- 2011-01-28
- Last Posted Date
- 2012-09-26
- Lead Sponsor
- Zymenex A/S
- Target Recruit Count
- 10
- Registration Number
- NCT01285700
- Locations
- 🇩🇰
Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark
Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
- First Posted Date
- 2010-12-30
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Zymenex A/S
- Target Recruit Count
- 10
- Registration Number
- NCT01268358
- Prev
- 1
- 2
- Next